Red Flags Detected

  • Delisting (new) — Company received formal NYSE notice of non-compliance with listing standards due to late 10-K filing.
NYSE: APUS Apimeds Pharmaceuticals US, Inc. 8-K

Apimeds receives NYSE delisting notice for late 2025 annual report; stock halted since April 2

Filed April 22, 2026 · Period ending April 17, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade APUS commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · Jun 3, 2026 1:18 AM